Calliditas Therapeutics A... (CALT)
NASDAQ: CALT
· Real-Time Price · USD
40.00
-0.04 (-0.10%)
At close: Sep 20, 2024, 10:00 PM
Calliditas Therapeutics AB (publ) Revenue
Calliditas Therapeutics AB (publ) reported an annual revenue of $1.21B, reflecting a 50.32% growth. For the quarter ending June 30, 2024, Calliditas Therapeutics AB (publ) generated $559.78M in revenue.
Revenue (ttm)
1.21B
Revenue Growth
50.32%
Price / Sales Ratio
5.76
Revenue / Employee
5.44M
Employees
222
Market Cap
2.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 1.21B | +50.32% |
| Dec 31, 2022 | 802.88M | +250.07% |
| Dec 31, 2021 | 229.35M | +26141.08% |
| Dec 31, 2020 | 874K | -99.53% |
| Dec 31, 2019 | 184.83M | +Infinity% |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | -100.00% |
| Dec 31, 2016 | 497K | +3.97% |
| Dec 31, 2015 | 478K | n/a |